Effect of continuous smoking reduction and abstinence on blood pressure and heart rate in smokers switching to electronic cigarettes

Internal and Emergency Medicine

Volumn 11, Issue 1, 2016, Pages 85-94

  Farsalinos, Konstantinos ^a   Cibella, Fabio ^b   Caponnetto, Pasquale ^c   Campagna, Davide ^c   Morjaria, Jaymin Bhagwanji ^d   Battaglia, Eliana ^c   Caruso, Massimo ^c   Russo, Cristina ^c   Polosa, Riccardo ^c,e  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b CNR   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF HULL   (United Kingdom)

^e UNIVERSITY OF CATANIA   (Italy)

Author keywords

Blood pressure; Electronic cigarette; Heart rate; Smoking cessation; Smoking reduction; Tobacco harm reduction

Indexed keywords

ADULT; BLOOD PRESSURE; CONTROLLED STUDY; ELECTRONIC CIGARETTE; FEMALE; HEART RATE; HUMAN; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PREVENTION AND CONTROL; RANDOMIZED CONTROLLED TRIAL; SMOKING; SMOKING CESSATION;

ADULT; BLOOD PRESSURE; ELECTRONIC CIGARETTES; FEMALE; HEART RATE; HUMANS; MALE; MIDDLE AGED; SMOKING; SMOKING CESSATION;

EID: 84958122389     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-015-1361-y     Document Type: Article

References (46)

1. World Health Organization (2008) Report on the global tobacco epidemic. www.who.int/tobacco/mpower/2008/en/index.html. Accessed 26 June 2015
2. Perk J, De Backer G, Gohlke H et al (2012) European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts). Eur Heart J 33(13):1635–1701
3. Edwards R (2004) The problem of tobacco smoking. BMJ 328:217–219
4. Prescott E, Hippe M, Schnohr P et al (1998) Smoking and risk of myocardial infarction in women and men: longitudinal population study. BMJ 316:1043–1047
5. Prescott E, Scharling H, Osler M et al (2002) Importance of light smoking and inhalation habits on risk of myocardial infarction and all cause mortality. A 22 year follow up of 12149 men and women in The Copenhagen City Heart Study. J Epidemiol Community Health 56:702–706
6. Teo KK, Ounpuu S, Hawken S, INTERHEART Study Investigators et al (2006) Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet 368(9536):647–658
7. Grassi G, Seravalle G, Calhoun DA et al (1994) Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 90:248–253
8. Primatesta P, Falaschetti E, Gupta S et al (2001) Association between smoking and blood pressure: evidence from the health survey for England. Hypertension 37(2):187–193
9. Al-Safi SA (2005) Does smoking affect blood pressure and heart rate? Eur J Cardiovasc Nurs 4(4):286–289
10. Lee DH, Ha MH, Kim JR et al (2001) Effects of smoking cessation on changes in blood pressure and incidence of hypertension: a 4-year follow-up study. Hypertension 37(2):194–198
11. Halimi JM, Giraudeau B, Vol S et al (2002) The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 20(2):187–193
12. Niskanen L, Laaksonen DE, Nyyssönen K et al (2004) Inflammation, abdominal obesity, and smoking as predictors of hypertension. Hypertension 44(6):859–865
13. Fagard RH (2009) Smoking amplifies cardiovascular risk in patients with hypertension and diabetes. Diabetes Care 32(Suppl 2):S429–S431
14. Zanchetti A, Hansson L, Dahlöf B et al (2001) Effects of individual risk factors on the incidence of cardiovascular events in the treated hypertensive patients of the Hypertension Optimal Treatment Study. HOT Study Group. J Hypertens 19(6):1149–1159
15. Mancia G, Fagard R, Narkiewicz K et al (2013) 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 34:2159–2219
16. Virdis A, Giannarelli C, Fritsch Neves M et al (2010) Cigarette smoking and hypertension. Curr Pharm Des 16(23):2518–2525
17. Caponnetto P, Campagna D, Papale G et al (2012) The emerging phenomenon of electronic cigarettes. Expert Rev Respir Med 6(1):63–74
18. Caponnetto P, Russo C, Bruno CM et al (2013) Electronic cigarette: a possible substitute for cigarette dependence. Monaldi Arch Chest Dis 79(1):12–19
19. Farsalinos KE, Romagna G, Tsiapras D et al (2014) Characteristics, perceived side effects and benefits of electronic cigarette use: a worldwide survey of more than 19,000 consumers. Int J Environ Res Public Health 11(4):4356–4373
20. Farsalinos KE, Romagna G, Tsiapras D et al (2013) Evaluating nicotine levels selection and patterns of electronic cigarette use in a group of “vapers” who had achieved complete substitution of smoking. Subst Abuse 7:139–146
21. Farsalinos KE, Polosa R (2014) Safety evaluation and risk assessment of electronic cigarettes as tobacco cigarettes substitutes: a systematic review. Ther Adv Drug Saf 5:67–86
22. Bullen C, Howe C, Laugesen M et al (2013) Electronic cigarettes for smoking cessation: a randomised controlled trial. Lancet 382(9905):1629–1637
23. Caponnetto P, Campagna D, Cibella F et al (2013) EffiCiency and Safety of an eLectronic cigAreTte (ECLAT) as tobacco cigarettes substitute: a prospective 12-month randomized control design study. PLoS One 8(6):e66317
24. Chobanian AV, Bakris GL, Black HR et al (2003) Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee. Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42(6):1206–1252
25. Bolliger CT, Zellweger JP, Danielsson T et al (2000) Smoking reduction with oral nicotine inhalers: double blind, randomised clinical trial of efficacy and safety. BMJ 321(7257):329–333
26. Cryer PE, Haymond MW, Santiago JV et al (1976) Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events. N Engl J Med 295:573–577
27. Benowitz NL, Kuyt F, Jacob P (1984) Influence of nicotine on cardiovascular and hormonal effects of cigarette smoking. Clin Pharmacol Ther 36:74–81
28. Scallan C, Doonan RJ, Daskalopoulou SS (2010) The combined effect of hypertension and smoking on arterial stiffness. Clin Exp Hypert 32(6):319–328
29. Seltzer CC (1974) Effect of smoking on blood pressure. Am Heart J 87:558–564
30. Goldbourt U, Medalie JH (1977) Characteristics of smokers, non-smokers and ex-smokers among 10,000 adult males in Israel. II. Physiologic, biochemical and genetic characteristics. Am J Epidemiol 105:75–86
31. Green MS, Jucha E, Luz Y (1986) Blood pressure in smokers and nonsmokers: epidemiologic findings. Am Heart J 111:932–940
32. Criqui MH, Mebane I, Wallace RB et al (1982) Multivariate correlates of adult blood pressures in nine North American populations: The Lipid Research Clinics Prevalence Study. Prev Med 11:391–402
33. Simons LA, Simons J, Jones AS (1984) The interactions of body weight, age, cigarette smoking and hormone usage with blood pressure and plasma lipids in an Australian community. Aust NZ J Med 14:215–221
34. Elliott JM, Simpson FO (1980) Cigarettes and accelerated hypertension. NZ Med J 91:447–449
35. Dyer AR, Stamler J, Shekelle RB et al (1982) Pulse pressure—III. Factors associated with follow-up values in three Chicago epidemiologic studies. J Chron Dis 35:275–282
36. Vasan RS, Larson MG, Leip EP et al (2001) Assessment of frequency of progression to hypertension in non-hypertensive participants in the Framingham Heart Study: a cohort study. Lancet 358:1682–1686
37. Qureshi AI, Suri MK, Kirmani JF et al (2005) Is prehypertension a risk factor for cardiovascular diseases? Stroke 36:1859–1863
38. Lonati L, Cuspidi C, Sampieri L et al (1993) Ultrasonographic evaluation of cardiac and vascular changes in young borderline hypertensives. Cardiology. 83:298–303
39. Escudero E, De Lena S, Graff-Iversen S et al (1996) Left ventricular diastolic function in young men with high normal blood pressure. Can J Cardiol 12:959–964
40. Kimura Y, Tomiyama H, Nishikawa E et al (1999) Characteristics of cardiovascular morphology and function in the high-normal subset of hypertension defined by JNC-VI recommendations. Hypertens Res 22:291–295
41. Klesges RC, Meyers AW, Klesges LM et al (1989) Smoking, body weight, and their effects on smoking behavior: a comprehensive review of the literature. Psychol Bull 106(2):204–230
42. Aubin H-J, Farley A, Aveyard P (2012) Weight gain in smokers after quitting cigarettes: meta-analysis. BMJ 10:345–439
43. Hatsukami DK, Kotlyar M, Allen S et al (2005) Effects of cigarette reduction on cardiovascular risk factors and subjective measures. Chest 128(4):2528–2537
44. Bolliger CT, Zellweger JP, Danielsson T et al (2002) Influence of long-term smoking reduction on health risk markers and quality of life. Nicotine Tob Res 4:433–439
45. Polosa R, Rodu B, Caponnetto P et al (2013) A fresh look at tobacco harm reduction: the case for the electronic cigarette. Harm Reduct J 10. doi:10.1186/1477-7517-10-19
46. Nutt DJ, Phillips LD, Balfour D et al (2014) Estimating the harms of nicotine-containing products using the MCDA approach. Eur Addict Res 20(5):218–225